期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
NT4-p53(N37)-HA2-TAT融合基因的克隆和鉴定
1
作者 白艳霞 马清涌 +1 位作者 杨广笑 王全颖 《山西医科大学学报》 CAS 2009年第12期1057-1061,F0003,共6页
目的构建NT4-p53(N37)-HA2-TAT融合基因表达盒并进行序列分析。方法应用互补引物二次PCR技术及T载体克隆法克隆p53(N37)基因,筛选阳性克隆、酶切鉴定并测序。扩增阳性重组质粒后用限制性内切酶切取p53(N37)和HA2-TAT片段连入pUC19/NT4... 目的构建NT4-p53(N37)-HA2-TAT融合基因表达盒并进行序列分析。方法应用互补引物二次PCR技术及T载体克隆法克隆p53(N37)基因,筛选阳性克隆、酶切鉴定并测序。扩增阳性重组质粒后用限制性内切酶切取p53(N37)和HA2-TAT片段连入pUC19/NT4质粒。结果克隆了p53(N37)基因,经酶切及测序证实结果正确;重组质粒pUC19/NT4-p53(N37)-HA2-TAT经限制性内切酶及琼脂糖凝胶电泳鉴定,结果显示酶切片段大小和理论值完全一致。结论通过基因克隆体外重组技术成功制备了含有NT4-p53(N37)-HA2-TAT表达盒的pUC/19质粒,为进一步开展肿瘤的基因治疗奠定了基础。 展开更多
关键词 p53(n37) P73 基因克隆 基因治疗 肿瘤
下载PDF
Cloning and sequencing of a DNA fragment encoding N37 apoptotic peptide derived from p53
2
作者 Yan-xia Bai1,Qing-yong Ma2,Guang-xiao Yang31. Department of Otorhinolaryngology Head and Neck Surgery,the First Affiliated Hospital,Medical School of Xi’an Jiaotong University,Xi’an 710061 2. Department of Hepatobiliary Surgery,the First Affiliated Hospital,Medical School of Xi’an Jiaotong University,Xi’an 710061 3. Xi’an Huaguang Biological Limited Company,Xi’an 710025,China. 《Journal of Pharmaceutical Analysis》 SCIE CAS 2009年第2期109-113,共5页
Objective It was reported that p53 apoptotic peptide (N37) could inhibit p73 gene through being bound with iASPP,which could induce tumor cell apoptosis. To further explore the function of N37,we constructed the cloni... Objective It was reported that p53 apoptotic peptide (N37) could inhibit p73 gene through being bound with iASPP,which could induce tumor cell apoptosis. To further explore the function of N37,we constructed the cloning plasmid of DNA fragment encoding p53 (N37) apoptotic peptide by using DNA synthesis and molecular biology methods. Methods According to human p53 sequence from the GenBank database,the primer of p53(N37) gene was designed using Primer V7.0 software. The DNA fragment encoding p53 (N37) apoptotic peptide was amplified by using self-complementation polymerase chain reaction (PCR) method and cloned into the pGEM-T Easy vector. The constructed plasmid was confirmed by endonuclease analysis and sequencing. Results The insertion of objective DNA fragment was confirmed by plasmid DNA enzyme spectrum analysis. p53(N37)gene was successfully synthesized chemically in vitro. The sequencing result of positive clone was completely identical to the human p53(N37) sequence in GenBank using BLAST software (http://www.ncbi.nlm.nih.gov/cgi-bin /BLASTn). Conclusion The cloning of DNA fragment encoding p53(N37) apoptotic peptide was constructed by using DNA synthesis and pGEM-T Easy cloning methods. With the constructed plasmid,we could further investigate the function of N37 peptide. 展开更多
关键词 p53(n37) P73 apoptotic peptide gene clone polymerase chain reaction
下载PDF
介导p73去阻抑肽表达的重组腺伴病毒的构建和鉴定 被引量:1
3
作者 白艳霞 闫利英 +2 位作者 马清涌 杨广笑 王全颖 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2012年第2期180-184,189,共6页
目的构建编码融合基因NT4-p53(N37)-HA2-TAT的重组腺伴病毒表达载体,为恶性肿瘤基因治疗的实验研究奠定基础。方法采用互补引物二次PCR法以及T载体克隆法获得p53(N37)基因克隆,酶切后将其连同穿膜肽HA2-TAT片段一起连入pUC19/NT4质粒,... 目的构建编码融合基因NT4-p53(N37)-HA2-TAT的重组腺伴病毒表达载体,为恶性肿瘤基因治疗的实验研究奠定基础。方法采用互补引物二次PCR法以及T载体克隆法获得p53(N37)基因克隆,酶切后将其连同穿膜肽HA2-TAT片段一起连入pUC19/NT4质粒,再将融合基因NT4-p53(N37)-HA2-TAT亚克隆至腺伴病毒的穿梭质粒pSSHG-CMV中,构建重组质粒pSSHG-CMV/NT4-p53(N37)-HA2-TAT并进行酶切鉴定;应用磷酸钙沉淀法,pSSHG-CMV/NT4-p53(N37)-HA2-TAT、辅助质粒pAAV-Ad,腺病毒全基因组质粒pFG140三种质粒共转染HEK293细胞,包装出重组腺伴病毒rAAV/NT4-p53(N37)-HA2-TAT并用斑点杂交法测定重组病毒的滴度;MTT比色法、流式细胞仪观察重组腺伴病毒rAAV/NT4-p53(N37)-HA2-TAT对HepG2细胞的抑制作用。结果克隆出p53(N37)基因,经酶切及测序证实结果正确;得到高滴度的(2×1013pfu/L)重组腺伴病毒表达载体并对HepG2细胞有明显的抑制作用,且这一作用是通过诱导肿瘤细胞凋亡实现的。结论通过分子克隆体外重组技术成功制备了rAAV/NT4-p53(N37)-HA2-TAT复制缺陷型重组腺伴病毒,为下一步开展在p53突变或缺失肿瘤中针对p73的靶向性肿瘤基因治疗研究奠定了基础。 展开更多
关键词 nt4-p53(n37)-ha2-tat p53(n37) P73 重组腺伴病毒 恶性肿瘤 基因治疗
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部